BridgeBio Oncology Therapeutics Inc. (BBOT) Financials

BBOT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 376.7 million 53.6 million
March 31, 2026 417.6 million 45.4 million
Dec. 31, 2025 448.4 million 37.3 million
Sept. 30, 2025 484.8 million 38.1 million

BBOT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -44.4 million 7.2 million
March 31, 2026 -35.9 million 3.9 million
Dec. 31, 2025 -42.3 million 2.9 million
Sept. 30, 2025 -71.2 million 2.8 million

BBOT Net Income

No data available :(

BBOT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 225.7 million 2.0 million -
March 31, 2026 252.3 million - 2.1 million
Dec. 31, 2025 425.5 million 2.2 million 2.8 million
Sept. 30, 2025 468.3 million - 2.9 million

BBOT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 80054
March 31, 2026 31.1 million
Dec. 31, 2025 31.1 million
Sept. 30, 2025 23.5 million

BBOT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 47000 49.2 million 11.0 million -
March 31, 2026 24000 39.8 million 6.4 million -
Dec. 31, 2025 73000 38.1 million 5.3 million -
Sept. 30, 2025 532996 35.1 million 14.1 million -

BBOT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 186000
Dec. 31, 2025 - 194000
Sept. 30, 2025 - -

BBOT

Price: $9.08

52 week price:
7.00
14.87

Earnings Per Share: -2.27 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 726.4 million

Links: